DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022
February 24 2022 - 4:30PM
DBV Technologies to Report Full Year 2021 Financial Results and
Business Updates on March 3, 2022
Montrouge, France, February 24, 2022
DBV Technologies to Report
Full Year 2021 Financial Results
and Business Updates on
March 3, 2022
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced that the Company will
host a conference call and live audio webcast on Thursday, March 3,
2022 at 5:00 p.m. ET to report full year 2021 financial results and
provide a corporate update.
This call is accessible via the below
teleconferencing numbers, followed by the reference ID:
50283860.United States: (866)
939-3921 Canada:
(866) 215-5508United Kingdom: 0808 238
9578 France:
0805 102 604
A live webcast of the call will be available on
the Investors & Media section of the Company’s website:
https://www.dbv-technologies.com/investor-relations/. A replay of
the presentation will also be available on DBV’s website after the
event.
About DBV
Technologies DBV Technologies is developing
Viaskin™, an investigational proprietary technology platform with
broad potential applications in immunotherapy. Viaskin is based on
epicutaneous immunotherapy, or EPIT™, DBV’s method of delivering
biologically active compounds to the immune system through intact
skin. With this new class of non-invasive product candidates, the
Company is dedicated to safely transforming the care of food
allergic patients. DBV’s food allergies programs include ongoing
clinical trials of Viaskin Peanut. DBV Technologies has global
headquarters in Montrouge, France, and North American operations in
Summit, NJ. The Company’s ordinary shares are traded on segment B
of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of
the SBF120 index, and the Company’s ADSs (each representing
one-half of one ordinary share) are traded on the Nasdaq Global
Select Market (Ticker: DBVT).
Investor Contact Anne PollakDBV
Technologies+1 857-529-2363anne.pollak@dbv-technologies.com
Media ContactAngela MarcucciDBV
Technologies+1 646-842-2393angela.marcucci@dbv-technologies.com
DBV Technologies (EU:DBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
DBV Technologies (EU:DBV)
Historical Stock Chart
From Apr 2023 to Apr 2024